Alterity Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for ATHE stock have an average target of 6.00, with a low estimate of 4.00 and a high estimate of 8.00. The average target predicts an increase of 75.44% from the current stock price of 3.42.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$4.00	$6.00	$8.00	$8.00
Change	+16.96%	+75.44%	+133.92%	+133.92%

* Price targets were last updated on Dec 12, 2024.

Analyst Ratings

The average analyst rating for ATHE stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Aug '24	Sep '24	Oct '24	Nov '24	Dec '24	Jan '25
Strong Buy	1	1	1	1	1	1
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason McCarthy Maxim Group	Maxim Group	Strong Buy Initiates $8	Strong Buy	Initiates	$8	+133.92%	Dec 12, 2024
Robert Wasserman Benchmark	Benchmark	Buy Reiterates $4	Buy	Reiterates	$4	+16.96%	Mar 7, 2024
Aydin Huseynov Ladenburg Thalmann	Ladenburg Thalmann	Strong Buy Maintains $20 → $10	Strong Buy	Maintains	$20 → $10	+192.40%	Jun 5, 2023
Aydin Huseynov Ladenburg Thalmann	Ladenburg Thalmann	Strong Buy Initiates $20	Strong Buy	Initiates	$20	+484.80%	Aug 3, 2022
Aydin Huseynov Benchmark	Benchmark	Buy Initiates $40	Buy	Initiates	$40	+1,069.59%	Aug 20, 2021

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

n/a

EPS Next Year

n/a

No financial forecasts available for this stock

Revenue Forecast

No data available

Revenue Growth

No data available

EPS Forecast

No data available

EPS Growth

No data available

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.